Sign in

CIK 0001599298

  • Large accelerated filer

Summit Therapeutics Inc.

Sign in to watch
Ticker
SMMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
371979717
Phone
+1 305-203-2034
Business address
601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
Former names
Summit Therapeutics plc, Summit Corp plc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-02 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +35,000 35,000
2026-01-02 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +17,796 $8.76 $156K 17,796
2025-01-02 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +35,000 35,000
2025-01-02 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +16,991 $9.18 $156K 16,991
2024-10-11 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +200,000 200,000
2024-01-02 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +35,000 35,000
2024-01-02 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +70,492 $1.32 $93K 105,492
2023-01-03 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +35,000 35,000
2023-01-03 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +44,400 $1.67 $74K 79,400
2022-01-03 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +25,000 25,000
2022-01-03 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +58,510 $1.13 $66K 83,510
2021-10-07 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +200,000 200,000
2021-10-07 Clark Kenneth A Director Grant or award · Stock Option (right to buy) +6,250 206,250

Page 1 of 1 · 13 trades